Critically, we observed strong synergy between MEK and CENPE inhibition as well as MEK and RRM1 inhibition in three different pancreatic cancer cells at several different drug concentrations by measuring combination index (CI <1)31,32 (Fig. 2e, f). This evidence concerns the gene MAP2K7 and pancreatic neoplasm.